Research Nester released a report titled “Stent Delivery System Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global stent delivery system market in terms of market segmentation by product, by diameter length, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Stent delivery system is used to insert stents into blocked blood vessels, mainly arteries, in order to open the passage and ensure a continuous blood flow through the vessels. The market for stent delivery system is anticipated to grow with a significant CAGR during the forecast period, i.e., 2019-2027. On the basis of product, the market is segmented into over-the-wire (OTW) delivery system, rapid exchange (RX) delivery system and others, out of which, the rapid exchange delivery system is estimated to witness the highest growth during the forecast period. The demand for such delivery systems is estimated to increase on account of growing requirement for delivery systems that are safe and easy to use and provide smooth delivery of stents into the body.
Increasing Risk Of Cardiovascular Disease To Drive The Market Growth By 2027
Cardiovascular disease is the number one cause of death, as suggested by W.H.O., and is responsible for causing 31% of all deaths every year across the world. As a result of heart related disorders, the demand for angioplasty and other procedures involving insertion of stents in the body is anticipated to rise, thereby leading to the growth of stent delivery system market.
Regionally, the market in North America is anticipated to hold the largest share in stent delivery system market which can be attributed to growing number of patients with cardiovascular diseases including coronary heart disease, stroke, heart attack and others. According to American Heart Association, the cardiovascular diseases led to 840,678 deaths in the U.S. in 2016, which was approximately 1 in every 3 deaths.
On the other hand, Asia-Pacific region is estimated to witness highest market growth during the forecast period as a result of increasing research and development activities in the healthcare sector in the region.
However, the high cost of treatment involving surgical procedures using stents is estimated to restrict the market growth as majority of the population cannot afford the expenses.
This report also provides the existing competitive scenario of some of the key players of the global stent delivery system market which includes company profiling of Boston Scientific Corporation, Abbott, B. Braun Melsungen AG, Medtronic, Stryker, Biotronik, ELLA-CS, Becton, Dickinson and Company, Svelte Medical and Terumo Europe NV. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global stent delivery system market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.